Latest Insights - page 64 | BiopharmaTrend

Formation Bio Secures $372 Million Series D Funding for AI-Driven Drug Development

Formation Bio, an AI-native pharmaceutical company, has raised $372 million in Series D financing, led by a16z and Sanofi. Additional investors include Sequoia, Thrive, Emerson Collective, Lachy Groom, SV Angel …

Continue ›››

Evaxion Biotech Receives Positive Feedback on Patent Application for Personalized Vaccine Targets

Evaxion Biotech A/S, a clinical-stage TechBio company known for its AI-Immunology™ powered vaccines, has received favorable feedback regarding its recent patent application for a novel type of personalized vaccine target.

Continue ›››

EvolutionaryScale Unveils ESM3 Generative AI Model for Advanced Protein Design

EvolutionaryScale has introduced its latest generative AI model, ESM3, which leverages NVIDIA H100 GPUs to enhance protein research and discovery. The new model, which is the third-generation of EvolutionaryScale’s ESM …

Continue ›››

Cromatic Launches AI-Powered 'Sourcerer' for Streamlined R&D Outsourcing in Life Sciences

Cromatic, a startup focused on life sciences research outsourcing, has introduced an AI-powered tool named Sourcerer. This tool is designed to allow users to efficiently identify relevant contract research organizations …

Continue ›››

This Company Anonymized 1.8 Trillion Records to Support Biomedical Research

In the rapidly evolving life sciences and healthcare landscape, the secure and privacy-preserving exchange and linkage of health data is paramount. The topic of biomedical data collection and processing received …

Continue ›››

85% of Healthcare Leaders Investing or Plan to Invest in Gen AI, According to the Largest Survey

Among many important helathcare tech topics discussed at the inagural HLTH Europe 2024 conference taking place on June 17-20 in Amsterdam, generative artificial intelligence (AI) has seemingly taken the central …

Continue ›››

Basecamp Research Introduces ZymCTRL: An Open-Source AI Tool for Enzyme Design

Basecamp Research, in collaboration with the Ferruz Laboratory at the Institute of Molecular Biology of Barcelona, has introduced ZymCTRL, an open-source tool utilizing generative AI to create enzyme sequences based …

Continue ›››

Enveda Biosciences Secures $55 Million to Accelerate Drug Discovery Efforts

Enveda Biosciences has successfully raised $55 million in a Series B2 financing round, bringing its total capital raised to $230 million. This influx of funds aims to accelerate the company's …

Continue ›››

Yonalink Completes Largest EHR-to-EDC Data Transfer Pilot in Clinical Trials

Yonalink, a Boston-based provider of EHR-to-EDC streaming solutions for clinical trials, has announced the successful completion of its largest live pilot study. Conducted across 21 medical centers in the United …

Continue ›››

Santa Ana Bio Secures $168 Million to Propel Precision Medicine for Inflammatory Diseases

Santa Ana Bio, a precision immunology company focused on developing targeted therapies for autoimmune and inflammatory diseases, has officially launched with $168 million in combined Series A and B funding. …

Continue ›››

Pioneering the Largest Foundation Model to Transform RNA Research: An Interview with Brendan Frey

Toronto-based “techbio” company Deep Genomics has just annouced major milestones with the opening of a new office and lab facility in Cambridge, Massachusetts, and the expansion of its Toronto office.

Continue ›››

QuantumPharm (XtalPi) Begins Trading on Hong Kong Stock Exchange

QuantumPharm, operating as XtalPi, an AI-driven drug research company from China, commenced trading on the Hong Kong Stock Exchange on Thursday.

Continue ›››